These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9582368)

  • 1. In vivo expression of an alternatively spliced human tumor message that encodes a truncated form of cathepsin B. Subcellular distribution of the truncated enzyme in COS cells.
    Mehtani S; Gong Q; Panella J; Subbiah S; Peffley DM; Frankfater A
    J Biol Chem; 1998 May; 273(21):13236-44. PubMed ID: 9582368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon skipping of cathepsin B: mitochondrial targeting of a lysosomal peptidase provokes cell death.
    Müntener K; Zwicky R; Csucs G; Rohrer J; Baici A
    J Biol Chem; 2004 Sep; 279(39):41012-7. PubMed ID: 15262981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA.
    Gong Q; Chan SJ; Bajkowski AS; Steiner DF; Frankfater A
    DNA Cell Biol; 1993 May; 12(4):299-309. PubMed ID: 8494608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alternative use of exons 2 and 3 in cathepsin B mRNA controls enzyme trafficking and triggers nuclear fragmentation in human cells.
    Müntener K; Zwicky R; Csucs G; Baici A
    Histochem Cell Biol; 2003 Feb; 119(2):93-101. PubMed ID: 12610728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death.
    Baici A; Müntener K; Willimann A; Zwicky R
    Biol Chem; 2006 Aug; 387(8):1017-21. PubMed ID: 16895470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon 2 of human cathepsin B derives from an Alu element.
    Berquin IM; Ahram M; Sloane BF
    FEBS Lett; 1997 Dec; 419(1):121-3. PubMed ID: 9426233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intracellular form of cathepsin B contributes to invasiveness in cancer.
    Szpaderska AM; Frankfater A
    Cancer Res; 2001 Apr; 61(8):3493-500. PubMed ID: 11309313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal subunit of artificially truncated human cathepsin B mediates its nuclear targeting and contributes to cell viability.
    Bestvater F; Dallner C; Spiess E
    BMC Cell Biol; 2005 Apr; 6(1):16. PubMed ID: 15807897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes.
    Berardi S; Lang A; Kostoulas G; Hörler D; Vilei EM; Baici A
    Arthritis Rheum; 2001 Aug; 44(8):1819-31. PubMed ID: 11508434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors.
    Qian F; Chan SJ; Gong QM; Bajkowski AS; Steiner DF; Frankfater A
    Biomed Biochim Acta; 1991; 50(4-6):531-40. PubMed ID: 1801719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the role of 5' alternative splicing and of the 3'-untranslated region of cathepsin B mRNA.
    Zwicky R; Müntener K; Csucs G; Goldring MB; Baici A
    Biol Chem; 2003 Jul; 384(7):1007-18. PubMed ID: 12956417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis.
    Sinha AA; Jamuar MP; Wilson MJ; Rozhin J; Sloane BF
    Prostate; 2001 Nov; 49(3):172-84. PubMed ID: 11746262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization and targeting of cathepsin E.
    Finley EM; Kornfeld S
    J Biol Chem; 1994 Dec; 269(49):31259-66. PubMed ID: 7983070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the 5' spliced form of human cathepsin B mRNA in colorectal mucosa and tumors.
    Hizel C; Ferrara M; Cure H; Pezet D; Dechelotte P; Chipponi J; Rio P; Bignon YJ; Bernard-Gallon D
    Oncol Rep; 1998; 5(1):31-4. PubMed ID: 9458288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two new exons and multiple transcription start points in the 5'-untranslated region of the human cathepsin-B-encoding gene.
    Berquin IM; Cao L; Fong D; Sloane BF
    Gene; 1995 Jul; 159(2):143-9. PubMed ID: 7622042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules.
    Schmucker B; Tang Y; Kressel M
    Hum Mol Genet; 1999 Aug; 8(8):1561-70. PubMed ID: 10401006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin B expression in human tumors.
    Berquin IM; Sloane BF
    Adv Exp Med Biol; 1996; 389():281-94. PubMed ID: 8861022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes.
    Zwicky R; Müntener K; Goldring MB; Baici A
    Biochem J; 2002 Oct; 367(Pt 1):209-17. PubMed ID: 12086583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of multiple cathepsin B mRNAs in murine B16a melanoma.
    Qian F; Frankfater A; Steiner DF; Bajkowski AS; Chan SJ
    Anticancer Res; 1991; 11(4):1445-51. PubMed ID: 1746902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatively spliced human type 1 angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms.
    Curnow KM; Pascoe L; Davies E; White PC; Corvol P; Clauser E
    Mol Endocrinol; 1995 Sep; 9(9):1250-62. PubMed ID: 7491117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.